Abbreviated Journal Title
J. Exp. Med.
TUMOR-NECROSIS-FACTOR; UBIQUITIN-CONJUGATING ENZYME; SUPPRESSOR CYLD; IMMUNE-RESPONSES; MESSENGER-RNA; CELL-DEATH; ACTIVATION; ISOPEPTIDASE; INFLAMMATION; DEGRADATION; Immunology; Medicine, Research & Experimental
The intensity and duration of macrophage-mediated inflammatory responses are controlled by proteins that modulate inflammatory signaling pathways. MCPIP1 (monocyte chemotactic protein-induced protein 1), a recently identified CCCH Zn finger-containing protein, plays an essential role in controlling macrophage-mediated inflammatory responses. However, its mechanism of action is poorly understood. In this study, we show that MCPIP1 negatively regulates c-Jun N-terminal kinase (JNK) and NF-kappa B activity by removing ubiquitin moieties from proteins, including TRAF2, TRAF3, and TRAF6. MCPIP1-deficient mice spontaneously developed fatal inflammatory syndrome. Macrophages and splenocytes from MCPIP1(-/-) mice showed elevated expression of inflammatory gene expression, increased JNK and I. B kinase activation, and increased polyubiquitination of TNF receptor-associated factors. In vitro assays directly demonstrated the deubiquitinating activity of purified MCPIP1. Sequence analysis together with serial mutagenesis defined a deubiquitinating enzyme domain and a ubiquitin association domain in MCPIP1. Our results indicate that MCPIP1 is a critical modulator of inflammatory signaling.
Journal of Experimental Medicine
Liang, Jian; Saad, Yasser; Lei, Tianhua; Wang, Jing; Qi, Dongfei; Yang, Qinglin; Kolattukudy, Pappachan E.; and Fu, Mingui, "MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappa B signaling" (2010). Faculty Bibliography 2010s. 437.